[HTML][HTML] A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer
K Grillone, G Caridà, F Luciano, A Cordua… - Journal of Translational …, 2024 - Springer
Targeting non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-
coding RNAs (lncRNAs), has recently emerged as a promising strategy for treating …
coding RNAs (lncRNAs), has recently emerged as a promising strategy for treating …
[HTML][HTML] The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment
S Wang, X Qi, D Liu, D Xie, B Jiang, J Wang… - Computational and …, 2023 - Elsevier
Urological malignancies are a major global health issue because of their complexity and the
wide range of ways they affect patients. There's a growing need for in-depth research into …
wide range of ways they affect patients. There's a growing need for in-depth research into …
TERRA G‐quadruplex stabilization behind the anti‐multiple myeloma activity: Novel insights about resveratrol pleiotropic effects
R Rocca, S Ascrizzi, EL Citriniti, F Scionti… - Archiv der …, 2024 - Wiley Online Library
Resveratrol (RSV) is a nutraceutical compound belonging to the nonflavonoid polyphenol
family, whose antioxidants, anti‐inflammatory, and antitumoral properties have been widely …
family, whose antioxidants, anti‐inflammatory, and antitumoral properties have been widely …